Eleni D. Lagadinou
University of Rochester(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Cancer therapeutics and mechanisms, Hematopoietic Stem Cell Transplantation, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells(2013)1,365 cited
- → Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells(2013)198 cited
- → c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia(2008)41 cited
- → Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity(2014)40 cited
- → Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia(2010)38 cited
- → Expression patterns of leptin receptor (OB-R) isoforms and direct in vitro effects of recombinant leptin on OB-R, leptin expression and cytokine secretion by human hematopoietic malignant cells(2009)36 cited
- → Disease-Related Anemia in Chronic Lymphocytic Leukemia Is Not Due to Intrinsic Defects of Erythroid Precursors: A Possible Pathogenetic Role for Tumor Necrosis Factor-Alpha(2009)27 cited
- → Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet(2010)25 cited
- → Bcl-2 Inhibitor ABT-263 Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells(2012)3 cited
- → Reactive Oxygen Species (ROS) Levels Define Functional Heterogeneity in Human Leukemia Stem Cells and Represent a Critical Parameter for Therapeutic Targeting(2011)2 cited